The development of hepatocellular carcinoma from liver cirrhosis during a follow-up study.

Gastroenterologia Japonica
H A Sulaiman

Abstract

A prospective study was carried out in 126 cases with liver cirrhosis attending the outpatient clinic of Hepatology of the Department of Internal Medicine, Dr. Cipto Mangunkusmo Hospital Jakarta, between August 1, 1982 and Dec. 31, 1985. The patients consisted of 82 men and 44 women and there were 45 HBsAg positive cases (36.7%). HBeAg was positive in 35.6% (16/45) and 40.0% were anti-HBe positive while both markers were negative in 24.4%. During the follow-up study 27 cases died. The cause of death was due to variceal bleeding in 9 cases (33.3%) and hepatic failure in 9 cases (33.3%). In 6 cases (22.2%) hepatocellular carcinoma (HCC) was the cause of death. Nine cases out of 94 traceable cases (13.7%) were developed HCC. They consisted of 4 cases out of 29 cases (13.8%) with HBsAg positive and 5 cases out of 65 cases (7.7%). But no significant difference was observed between both groups. The length of observation period from the first time of diagnosis until development of HCC was from 1 to 6 years with an average of 2.9 years.

References

Jul 11, 1970·Lancet·S J HadziyannisA P Afroudakis
May 1, 1984·Seminars in Liver Disease·M C Kew, H Popper
Jun 15, 1980·International Journal of Cancer. Journal International Du Cancer·H ObataK Nishioka

❮ Previous
Next ❯

Citations

Sep 14, 2006·The American Journal of Gastroenterology·Fasiha KanwalBrennan M R Spiegel
Sep 27, 2007·Alimentary Pharmacology & Therapeutics·E HuangB M R Spiegel
Oct 3, 2018·Journal of Clinical and Translational Hepatology·Marianna G Mavilia, George Y Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.